2026-02-10 09:12Financial Performance - In Q4 2025, the company's sales revenue was $2,488.7 million, a 4.5% increase from Q3 2025's revenue of $2,381.8 million[5]. - The gross profit for Q4 2025 was $478.1 million, with a gross margin of 19.2%, down from 22.0% in Q3 2025[5]. - For the full year 2025, the company reported unaudited sales revenue of $9,326.8 million, a 16.2% increase compared to $8,029.9 million in 2024[5]. - The net profit attributable to shareholders for 2025 was $685.1 million, representing a 39.1% increase from $492.7 million in 2024[5]. - Q4 2025 revenue reached $2,488.7 million, a 4.5% increase from Q3 2025 and a 12.8% increase year-over-year[16]. - Q4 2025 net income was $203.4 million, a 35.5% decrease from Q3 2025, with earnings per share remaining at $0.02[16][25]. - Operating profit for Q4 2025 was $298,620, a decrease of 15% compared to $351,069 in Q3 2025[32]. Capital Expenditures and Capacity - Capital expenditures for 2025 were $8.1 billion, with an expected monthly capacity of 1,059,000 8-inch wafers by year-end, an increase of approximately 110,000 wafers year-over-year[7]. - Capital expenditures for Q4 2025 were $2,407.5 million, with total capital expenditures for the year estimated at approximately $8.1 billion[20]. - The company’s production capacity increased to 1,058,750 8-inch equivalent wafers in Q4 2025, up from 1,022,750 in Q3 2025[18]. - The company anticipates that the growth rate of sales revenue in 2026 will exceed the average of comparable peers, with capital expenditures expected to remain roughly the same as in 2025[7]. Operating Expenses - Operating expenses in Q4 2025 were $179.5 million, a 4.5% increase from Q3 2025, while R&D expenses rose to $239.7 million, an 18.0% increase[22][24]. - Research and development expenses for Q4 2025 were $239,676, up 17.9% from $203,147 in Q3 2025, indicating increased investment in innovation[32]. Cash Flow and Liquidity - Net cash from operating activities for Q4 2025 was $1,343,934, up 42.8% from $941,112 in Q3 2025[30]. - The current ratio improved to 2.3 in Q4 2025 from 1.8 in Q3 2025, indicating better short-term financial health[28]. - Cash and cash equivalents rose significantly to $5,872,500 in Q4 2025, compared to $3,481,713 in Q3 2025, marking a 68.6% increase[34]. - The net cash used in investing activities was (1,546,087), a decrease from (2,062,136) in the previous quarter, indicating an improvement of about 25%[38]. - Cash inflows from financing activities amounted to 2,561,778, compared to a cash outflow of (489,594) in the previous quarter, marking a significant turnaround[38]. Market Share and Sales Volume - Total wafer sales in Q4 2025 were 2,514,970 units, a 0.6% increase from Q3 2025 and a 26.3% increase year-over-year[19]. - The company’s market share in the China region accounted for 87.6% of total revenue in Q4 2025, slightly up from 86.2% in Q3 2025[17]. Depreciation and Other Income - The gross profit margin for Q4 2025 was impacted by a 15.2% increase in depreciation and amortization costs, totaling $926.6 million[21][22]. - Other income for Q4 2025 showed a net loss of $72.1 million, significantly higher than the loss of $14.0 million in Q3 2025[23]. - Depreciation and amortization expenses rose to 1,069,773 from 995,857, indicating an increase of about 7.4%[38].